Health X Platform reported a consolidated net loss of ₹1.4 crore for the financial year ended March 31, 2026, narrowing significantly from a net loss of ₹133.5 crore in the previous year. The company's revenue from operations rose 20% to ₹1,305.9 crore in FY26, compared to ₹1,088.1 crore in FY25, primarily led by its Healthcare Network segment. The Board of Directors approved the audited standalone and consolidated financial results at its meeting held on May 30, 2026. The company filed an investor presentation with exchanges on June 1, 2026, detailing its strategic priorities and operational metrics.

Consolidated Financial Performance

The company's total comprehensive income for the year stood at ₹0.74 crore, a turnaround from the total comprehensive loss of ₹1,339.9 crore reported in FY25. For the quarter ended March 31, 2026, the company reported a net loss of ₹12.9 crore, compared to a net profit of ₹17.6 crore in the corresponding quarter of the previous year. Revenue from operations for the quarter increased to ₹378.1 crore from ₹281.9 crore in the same period last year. The statutory auditors, M/s JKVS & Co, provided an unmodified opinion on the standalone and consolidated audited financial results.

Segment and Operational Highlights

The Healthcare Network segment was the primary revenue driver, contributing ₹1,283.1 crore for the year, while the Financial Services segment reported revenue of ₹94.4 crore. The company, which changed its name from Sastasundar Ventures Limited during the year, operates as a Core Investment Company with a single reportable business segment within India. Exceptional items for the year totaled a loss of ₹1.1 crore, compared to a loss of ₹190.5 crore in the previous year. The company highlighted that working capital days improved to 18 days in Q4 FY26 from 23 days in Q4 FY25, representing a 31% year-over-year decrease.

Strategic Priorities and Capital Efficiency

The company outlined strategic priorities for the next five years, targeting a CAGR of 30%+ through customer acquisition, geographic penetration, and category expansion. It plans to integrate AI across the value chain for counselling and process automation. Capital efficiency metrics showed that net capital deployed in the Intellectual Property Rights (IPR) of the business stood at ₹119 crore. The company operates 62,000 retail pharmacies and utilizes 50,000+ SKUs from 700+ vendors, with a purchase return rate of less than 1%.

Standalone Results and Governance

On a standalone basis, the company reported a net loss of ₹0.95 crore for FY26, widening from a net loss of ₹0.71 crore in FY25. Total income decreased to ₹0.76 crore from ₹1.20 crore in the previous year. The Board re-appointed M/s. Priya Gupta & Co., Chartered Accountants, as the Internal Auditor for the financial year 2026-27.

Key Financial Metrics (Consolidated)

Health X Platform Limited has announced that its board of directors will meet on Saturday, May 30, 2026. The primary agenda of the meeting is to consider and approve the audited standalone and consolidated financial results of the company for the quarter and financial year ended March 31, 2026.

The meeting is being convened pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The board will review the performance of the company for the fourth quarter of the fiscal year 2026 and the full fiscal year.

In a disclosure related to the upcoming results, the company informed that the trading window for dealing in the securities of the company shall remain closed. This closure is effective until 48 hours after the declaration of the financial results to the stock exchanges, continuing from the previous closure notice dated March 25, 2026.

Key Meeting Details

The company, formerly known as Sastasundar Ventures Limited, has its registered office at Azimganj House, 2nd Floor, 7, Abanindra Nath Thakur Sarani, Kolkata. The intimation was signed by Pratap Singh, Company Secretary and Compliance Officer.